NCT03767283 is a clinical trial in Antibiotic Resistant Strain, sponsored by Assiut University.

Who is sponsoring NCT03767283?

NCT03767283 is sponsored by Assiut University.

What condition does NCT03767283 study?

NCT03767283 studies Antibiotic Resistant Strain.

Is NCT03767283 still recruiting?

NCT03767283 is currently status unknown. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT03767283

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae

Status unknown Last updated 18 January 2020

What this trial tests

trial in Antibiotic Resistant Strain in 50 participants. Status unknown.

Timeline

5 July 2019

Primary endpoint
10 June 2021

7 December 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	5 July 2019
Primary completion	10 June 2021
Estimated completion	7 December 2021
Sites	1 location across Egypt

Conditions studied

Antibiotic Resistant Strain — all drugs for Antibiotic Resistant Strain →

Sponsor

Assiut University

Who can join

Adults 2 to 50, any sex, with Antibiotic Resistant Strain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Klebsiella pneumoniae is an important pathogen that frequently causes nosocomial community-acquired and infections, including pneumonia, urinary tract infections, bloodstream infections, pyogenic liver abscesses, and septic shock. An emerging co-existence of carbapenems and fluoroquinolone resistance in Klebsiella pneumoniae is causing major difficulty in treating infections caused by such pathogen

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Antibiotic Resistant Strain

Currently open trials in the same condition.

NCT04460313 — Nasopharyngeal Carriage of S. Pneumoniae · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03767283 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03767283.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing